What is the current Japan In-vitro Diagnostics Market size?

The Japan In-vitro Diagnostics Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029) Read More

Who are the key players in Japan In-vitro Diagnostics Market?

Abbott, Becton Dickinson & Company, Biomerieux, Bio-rad Laboratories Inc. and Qiagen are the major companies operating in the Japan In-vitro Diagnostics Market. Read More

What years does this Japan In-vitro Diagnostics Market cover?

The report covers the Japan In-vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan In-vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Japan In-vitro Diagnostics Market Share

Statistics for the 2023 & 2024 Japan In-vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Japan In-vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Japan In-vitro Diagnostics Industry

The market comprises of major market players and these players are moreover focusing on research and development in order to form a stable and safe formulation. The market has been noticing technological developments on a large scale for the past couple of years. For instance, in July 2017 Sysmex Corporation and bioMérieux announced that they had agreed to transfer all of Sysmex holdings in Sysmex bioMérieux Co., Ltd. (Tokyo, Japan) to bioMérieux. Key players in Japan In-vitro Diagnostics market are Biomérieux, Abbott Laboratories, Bayer AG, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Nippon Becton Dickinson Company, Roche Diagnostics and Siemens amongst others.